ESCO TECHNOLOGIES INC

**Signal Note: Driehaus Capital initiates $44M position in ESCO Technologies** ESCO is an industrial diversification play rather than pure-play biotech—the company manufactures specialized filtration, sterilization, and contamination control equipment for pharma/biotech manufacturing. Driehaus's entry suggests conviction in sustained capital intensity across biopharma supply chains, likely driven by nearshoring trends and elevated GMP manufacturing standards post-pandemic. No specific near-term catalyst is apparent; this appears positioned as a thematic bet on biotech infrastructure demand rather than a product-driven catalyst play.